Review: taking Uloric and Diovan together


Summary

Drug interactions are reported among people who take Uloric and Diovan together. This review analyzes the effectiveness and drug interactions between Uloric and Diovan. It is created by eHealthMe based on reports of 128 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Uloric

Uloric has active ingredients of febuxostat. It is often used in gout. (latest outcomes from Uloric 3,562 users)

Diovan

Diovan has active ingredients of valsartan. It is often used in high blood pressure. (latest outcomes from Diovan 64,715 users)

On Sep, 29, 2016

128 people who take Uloric, Diovan are studied.


Number of reports submitted per year:

Uloric and Diovan drug interactions.

Drug effectiveness over time:

Uloric:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Diovan:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Uloric:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)
Diovan:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Uloric:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)
Diovan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • toxic epidermal necrolysis
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • diabetes mellitus
  • febrile neutropenia
  • generalised oedema
  • abdominal pain
  • arteriovenous fistula
  • blood creatinine increased
  • blood sodium decreased
1 - 6 months:
  • activities of daily living impaired
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • anxiety
  • diabetes mellitus
  • diabetic ketoacidosis
  • dizziness
  • febrile neutropenia
  • generalised oedema
  • hepatic enzyme increased
1 - 2 years:
  • blood creatinine increased
  • blood pressure increased
  • blood urea increased
  • blood uric acid increased
  • cardiac failure
  • diabetes mellitus inadequate control
  • gamma-glutamyltransferase increased
  • pancreatitis chronic
  • protein urine present
  • urinary retention
2 - 5 years:
  • coagulopathy
  • decreased appetite
  • hyperkalaemia
  • liver disorder
  • renal disorder
  • fall
  • haemorrhage intracranial
  • dizziness
  • anxiety
  • asthenia
5 - 10 years:
  • dizziness
10+ years:
  • blood creatinine increased
  • blood pressure increased
  • blood urea increased
  • cardiac failure
  • gamma-glutamyltransferase increased
  • protein urine present
not specified:
  • diarrhoea
  • dizziness
  • asthenia
  • gout
  • fatigue
  • headache
  • blood uric acid increased
  • fall
  • pain in extremity
  • drug ineffective

Most common drug interactions by gender *:

female:
  • diarrhoea
  • asthenia
  • blood uric acid increased
  • renal disorder
  • rhinorrhoea
  • dizziness
  • headache
  • palpitations
  • toxic epidermal necrolysis
  • skin exfoliation
male:
  • dizziness
  • diarrhoea
  • gout
  • blood creatinine increased
  • fall
  • fatigue
  • pain in extremity
  • asthenia
  • back pain
  • blood urea increased

Most common drug interactions by age *:

2-9:
  • back pain
20-29:
  • blood creatine phosphokinase increased
  • diabetic ketoacidosis
  • gastroenteritis
  • hyperglycaemia
  • hyperlipidaemia
  • hyperuricaemia
  • iron deficiency anaemia
  • menorrhagia
  • nasopharyngitis
  • osteonecrosis
30-39:
  • back pain
  • blood uric acid increased
  • fatigue
  • gout
  • white blood cell count increased
40-49:
  • dizziness
  • gout
  • nausea
50-59:
  • blood creatinine increased
  • blood urea increased
  • cardiac failure
  • gamma-glutamyltransferase increased
  • protein urine present
  • acute graft versus host disease in skin
  • acute myeloid leukaemia
  • anxiety
  • blood pressure increased
  • diabetes mellitus
60+:
  • diarrhoea
  • asthenia
  • dizziness
  • blood uric acid increased
  • decreased appetite
  • fall
  • gout
  • headache
  • pain in extremity
  • rhinorrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Uloric and Diovan?

Can you answer these questions?

More questions for: Uloric, Diovan

You may be interested in these reviews

More reviews for: Uloric, Diovan

On eHealthMe, Uloric (febuxostat) is often used to treat gout. Diovan (valsartan) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.